Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer’s dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial
Kyung Won Park(Deleted Institution), Seong Hye Choi(Inha University), Bon D. Ku(Catholic Kwandong University International St. Mary's Hospital), Oh Dae Kwon(Daegu Catholic University), Byeong C. Kim(Chonnam National University Hospital), Mee Young Park(Yeungnam University), Eun Joo Chung(National Institutes of Health), Bora Yoon(Konyang University), Heeyoung Kang(Gyeongsang National University), Kwang K. Kim(Dongguk University), Kee Hyung Park(Deleted Institution), Hyun Jeong Han(Kyungdong University), Eun Joo Kim(Yonsei University), Sang Won Park(Daegu Fatima Hospital), Ho‐Won Lee(Kyungpook National University), Sang Won Seo(Samsung Medical Center), Jae‐Hyeok Lee(Korea University), Jae Cheol Kwon, Hyon-Ah Yi(Keimyung University), SangYun Kim(University of Minnesota), Yong S. Shim(The Catholic University of Korea Seoul St. Mary's Hospital), Dong Won Yang(St. Mary's Hospital)
Cited by 11
Related Papers
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease
|European Journal of Nuclear Medicine and Molecular Imaging|2008|277
Endovascular Treatment and the Outcomes of Atherosclerotic Intracranial Stenosis in Patients With Hyperacute Stroke
|Neurosurgery|2015|179
Ensembles of Patch-Based Classifiers for Diagnosis of Alzheimer Diseases
|IEEE Access|2019|150